BROCCA, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 4.107
AS - Asia 1.153
EU - Europa 728
AF - Africa 296
SA - Sud America 274
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 12
Totale 6.612
Nazione #
US - Stati Uniti d'America 3.953
SG - Singapore 365
CN - Cina 306
BR - Brasile 181
HK - Hong Kong 150
IT - Italia 123
DE - Germania 101
FI - Finlandia 55
SE - Svezia 53
PL - Polonia 49
VN - Vietnam 49
GB - Regno Unito 43
NL - Olanda 32
RU - Federazione Russa 27
AR - Argentina 24
IN - India 24
JP - Giappone 23
IE - Irlanda 21
ZA - Sudafrica 19
CI - Costa d'Avorio 17
MX - Messico 17
CA - Canada 15
FR - Francia 15
TR - Turchia 15
AE - Emirati Arabi Uniti 14
CZ - Repubblica Ceca 13
ES - Italia 13
MG - Madagascar 13
UA - Ucraina 13
AZ - Azerbaigian 12
JM - Giamaica 12
MR - Mauritania 12
BZ - Belize 11
CL - Cile 11
CR - Costa Rica 11
DO - Repubblica Dominicana 11
GR - Grecia 11
HN - Honduras 11
NZ - Nuova Zelanda 11
EC - Ecuador 10
EG - Egitto 10
GE - Georgia 10
HU - Ungheria 10
IS - Islanda 10
LV - Lettonia 10
MD - Moldavia 10
PT - Portogallo 10
AO - Angola 9
AT - Austria 9
CD - Congo 9
GN - Guinea 9
IR - Iran 9
KR - Corea 9
MU - Mauritius 9
MY - Malesia 9
PE - Perù 9
TH - Thailandia 9
UY - Uruguay 9
VE - Venezuela 9
ZM - Zambia 9
AU - Australia 8
BE - Belgio 8
BY - Bielorussia 8
CV - Capo Verde 8
CY - Cipro 8
DK - Danimarca 8
GF - Guiana Francese 8
GT - Guatemala 8
IQ - Iraq 8
NC - Nuova Caledonia 8
RW - Ruanda 8
SA - Arabia Saudita 8
TN - Tunisia 8
UG - Uganda 8
ZW - Zimbabwe 8
AF - Afghanistan, Repubblica islamica di 7
AL - Albania 7
AM - Armenia 7
BG - Bulgaria 7
CM - Camerun 7
ET - Etiopia 7
GA - Gabon 7
ID - Indonesia 7
IL - Israele 7
KE - Kenya 7
KG - Kirghizistan 7
KH - Cambogia 7
KZ - Kazakistan 7
LB - Libano 7
LC - Santa Lucia 7
MA - Marocco 7
ML - Mali 7
NI - Nicaragua 7
NP - Nepal 7
PG - Papua Nuova Guinea 7
RE - Reunion 7
SO - Somalia 7
XK - ???statistics.table.value.countryCode.XK??? 7
BB - Barbados 6
BF - Burkina Faso 6
Totale 6.346
Città #
Fairfield 762
Ashburn 380
Woodbridge 353
Houston 323
Seattle 270
Singapore 252
Cambridge 247
Chandler 246
Wilmington 226
Ann Arbor 214
Hong Kong 139
Santa Clara 105
Beijing 82
San Diego 64
Boardman 58
Munich 55
Des Moines 46
Medford 45
Princeton 45
Bytom 39
Helsinki 26
Padova 26
Los Angeles 24
Nanjing 22
Roxbury 21
Milan 20
Jinan 18
Abidjan 17
Dublin 17
Turku 16
Guangzhou 15
Dong Ket 14
Shenyang 14
São Paulo 14
Antananarivo 12
Baku 12
Buffalo 12
Chicago 12
Ho Chi Minh City 12
Shanghai 12
Tokyo 12
London 11
Nanchang 11
Nouakchott 11
Hanoi 10
Riga 10
Conakry 9
Hebei 9
Luanda 9
Lusaka 9
Auckland 8
Council Bluffs 8
Hefei 8
Kampala 8
Kigali 8
New York 8
Noumea 8
San Francisco 8
San José 8
Tbilisi 8
Bamako 7
Belize City 7
Cape Town 7
Castries 7
Cayenne 7
Changsha 7
Chisinau 7
Dallas 7
Harare 7
Kingston 7
Libreville 7
Managua 7
Montevideo 7
Phnom Penh 7
Port Moresby 7
Praia 7
Rio de Janeiro 7
Vienna 7
Athens 6
Auburn 6
Bishkek 6
Boston 6
Bridgetown 6
Budapest 6
Cagliari 6
Cotonou 6
Curitiba 6
Dakar 6
Dushanbe 6
Guatemala City 6
Istanbul 6
Johannesburg 6
Kinshasa 6
Mamoudzou 6
Panama City 6
Tianjin 6
Ulan Bator 6
Vientiane 6
Abu Dhabi 5
Amman 5
Totale 4.724
Nome #
Effect of percutaneous ventricular assist devices on renal function 220
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections 208
Optimizing a kidney stress test to evaluate renal functional reserve 194
Including Relative Adrenal Insufficiency in Definition and Classification of Acute-on-Chronic Liver Failure 186
Fam20C-mediated phosphorylation of osteopontin is critical for its secretion but dispensable for its action as a cytokine in the activation of hepatic stellate cells in liver fibrogenesis 184
Pro-Apoptotic Effects of Plasma from Patients with Cardiorenal Syndrome on Human Tubular Cells 178
High cut-off hemofiltration versus standard hemofiltration: A pilot assessment of effects on indices of apoptosis 169
A comparison of three commercial platforms for urinary NGAL in critically ill adults 167
Advances in the pathogenesis of cardiorenal syndrome type 3 164
In vitro Cytotoxicity of Bisphenol A in Monocytes Cell Line 160
Cardiorenal Syndrome Type 1: Activation of Dual Apoptotic Pathways 158
Thoughts modulate the expression of inflammatory genes and may improve the coronary blood flow in patients after a myocardial infarction 158
Outcomes and Mortality of Grade 1 Ascites and Recurrent Ascites in Patients With Cirrhosis 157
Cardiorenal syndrome type 1: A defective regulation of monocyte apoptosis induced by proinflammatory and proapoptotic factors 155
Cardiorenal Syndrome Type 5: In Vitro Cytotoxicity Effects on Renal Tubular Cells and Inflammatory Profile 154
The hemodynamic and nonhemodynamic crosstalk in cardiorenal syndrome type 1 154
Hemolytic Uremic Syndrome and Kidney Transplantation: A Case Series and Review of the Literature 153
The Role of Cell-Free Plasma DNA in Critically Ill Patients with Sepsis 152
Elevated Levels of Procalcitonin and Interleukin-6 are Linked with Postoperative Complications in Cardiac Surgery 151
Fabry’s disease: an example of cardiorenal syndrome type 5 149
The role of cell-free plasma DNA in peritoneal dialysis patients with peritonitis 148
Cardiorenal syndrome type 4: From chronic kidney disease to cardiovascular impairment 145
Cardiorenal Syndrome Type 5 in Sepsis: Role of Endotoxin in Cell Death Pathways and Inflammation 144
Molecular and Genetic Mechanisms Involved in the Pathogenesis of Cardiorenal Cross Talk 144
Procalcitonin and Interleukin-6 Levels: Are They Useful Biomarkers in Cardiac Surgery Patients? 143
Predictors of Early Readmission in Patients With Cirrhosis After the Resolution of Bacterial Infections. 143
Oxidative stress: Dual pathway induction in cardiorenal syndrome type 1 pathogenesis 143
Delayed Nephrology Consultation and High Mortality on Acute Kidney Injury: A Meta-Analysis 138
In-vitro Evaluation of proBPN Extracorporeal Removal during Hemodialysis with High Cut-Off Membrane 137
Rationale for the Evaluation of Renal Functional Reserve in Living Kidney Donors and Recipients: A Pilot Study 137
Endotoxin Effects on Cardiac and Renal Functions and Cardiorenal Syndromes 132
Peritoneal Cell-free DNA: an innovative method for determining acute cell damage in peritoneal membrane and for monitoring the recovery process after peritonitis 131
Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis 130
The Role of Endotoxin in the Setting of Cardiorenal Syndrome Type 5 127
Epigenetics: a potential key mechanism involved in the pathogenesis of cardiorenal syndromes 124
Pro-inflammatory cytokines: A possible relationship with dialytic adequacy and serum albumin in peritoneal dialysis patients 122
Infections complicating cirrhosis 119
Renal Function in Cirrhosis: A Critical Review of Available Tools 116
Characterization of molecular pathways involved in acute and acute-on-chronic liver disease 113
In-vitro Evaluation of NGAL Extracorporeal Removal during Hemodialysis with High Cut-Off Membrane 111
Cardio-pulmonary-renal interactions: A multidisciplinary approach 110
Mitochondria-targeted antioxidant mitoquinone attenuates liver inflammation and fibrosis in cirrhotic rats 107
Brief Review and a Clinical Case of Hemolytic Uremic Syndrome Associated with Interferon β Treatment 102
Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event 97
Subclinical Contrast-Induced Acute Kidney Injury in Patients Undergoing Cerebral Computed Tomography 93
Diagnostic and prognostic performance of urinary neutrophil gelatinase-associated lipocalin in patients with cirrhosis and acute kidney injury 89
Preoperative Renal Functional Reserve Predicts Risk of Acute Kidney Injury After Cardiac Operation 78
Totale 6.694
Categoria #
all - tutte 22.040
article - articoli 21.511
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.551


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021428 0 0 0 18 13 14 20 47 84 52 107 73
2021/2022673 37 60 94 55 27 37 39 72 32 17 58 145
2022/2023502 97 65 4 66 65 57 9 41 69 1 19 9
2023/2024258 12 24 43 27 15 20 28 21 5 10 33 20
2024/20251.170 7 100 47 68 151 37 53 94 69 55 198 291
2025/20261.460 213 386 617 244 0 0 0 0 0 0 0 0
Totale 6.694